# Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-delgocitinib-in-adult-patients-with-atopic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Motoi Takenaka,Mai Matsumoto,Hiroyuki Murota,Sachie Inoue,Hidetoshi Shibahara,Kazufumi Yoshida,Sotaro Takigawa,Atsushi Ishimoto |
| Citations | 4 |
| DOI | 10.1002/cia2.12163 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cia2.12163 |
| OpenAlex ID | https://openalex.org/W3137348947 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Kazufumi Yoshida](https://scholariq.org/researchers/kazufumi-yoshida/)
- [Atsushi Ishimoto](https://scholariq.org/researchers/atsushi-ishimoto/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [IL-33, ST2, and ILC Pathways](https://scholariq.org/topics/il-33-st2-and-ilc-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.